A Study to Evaluate the Safety of Recombinant Herpes Zoster Vaccine for Healthy Individuals
Clinical trial NCT06932523 · RECRUITING
Trial details
- NCT number
- NCT06932523
- Sponsor
- Shanghai Institute Of Biological Products
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-04
- Primary completion
- 2026-06-30
- Enrollment
- 645
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.